Titre:drugs.com | prescription drug information, interactions & side effects
La description :prescription drug information and news for professionals and consumers. search our drug database for comprehensive prescription and patient information on 24,000 drugs online....
Classement Alexa Global: # 1,551,Alexa Classement dans United States est # 630
Server:Apache...
L'adresse IP principale: 23.193.188.191,Votre serveur United States,New York City
ISP:Akamai Technologies Inc. TLD:com Code postal:us
Ce rapport est mis à jour en 31-Jul-2018
Created Date:
1998-12-18
Changed Date:
2015-11-24
Expires Date:
2022-12-18
Données techniques du drugs.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte drugs.com.Actuellement, hébergé dans United States et son fournisseur de services est Akamai Technologies Inc. .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 1, mail exchanger = aspmx.l.google.com. MX preference = 10, mail exchanger = alt4.aspmx.l.google.com. MX preference = 10, mail exchanger = alt3.aspmx.l.google.com. MX preference = 5, mail exchanger = alt2.aspmx.l.google.com. MX preference = 5, mail exchanger = alt1.aspmx.l.google.com.
HtmlToText
drugs.com | prescription drug information, interactions & side effects skip to content search drugs.com all all consumer professional pill id interactions news fda alerts approvals pipeline clinical trials care notes encyclopedia dictionary natural products browse all medications: a b c d e f g h i j k l m n o p q r s t u v w x y z advanced search topics & tools sign in sign in register menu close account sign in register now drugs a-z a-z drug index drugs by condition drugs by class compare drugs generic drugs otc drugs international drugs natural products veterinary products drug side effects dosage guides pregnancy warnings breastfeeding warnings pricing & coupons inactive ingredients advanced search phonetic search info en español pill identifier interactions checker news q & a pro edition apps more videos slideshows newsletters pricing & coupon guide facebook twitter google plus youtube • • • • popular having trouble identifying your medications? try the pill identifier quickly identify pills, tablets and capsules using the web's most comprehensive pill identification wizard. get started featured tool worried about drug interactions? use the interactions checker the drug interactions tool allows you to check for drug-drug and drug-food interactions. check now featured tool discover treatment options with the symptom checker this interactive decision guide helps identify the underlying cause of common symptoms. get started featured tool custom search for medical transcriptionists ? use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available. get started pill identifier identify your medication interactions checker check for drug interactions medical transcription phonetic search assistant drug information a to z drug list drugs by condition drugs by class dosage side effects pregnancy warnings harvard health guide generic drugs otc database inactive ingredients veterinary drugs international drugs info en español pricing & coupon guide tools interactions checker pill identifier symptom checker medication record mobile apps drug imprint codes forums q&a - faq compare drugs news & alerts medical news clinical trial results fda drug alerts fda consumer updates new fda approvals new drug applications drug shortages video center popular articles health & medication slideshows professionals resource center medical dictionary medical conferences patient care notes top 100 drugs abilify acetaminophen adderall alprazolam ambien amitriptyline amlodipine amoxicillin ativan atorvastatin augmentin azithromycin baclofen benadryl benzonatate bupropion buspirone carvedilol celexa cephalexin cetirizine cialis ciprofloxacin citalopram clindamycin clonazepam clonidine cyclobenzaprine cymbalta diazepam diclofenac diphenhydramine doxycycline duloxetine effexor eliquis escitalopram famotidine fentanyl flexeril fluoxetine furosemide gabapentin hydrochlorothiazide hydrocodone hydroxyzine ibuprofen klonopin levothyroxine lexapro lipitor lisinopril lithium loratadine lorazepam losartan lyrica melatonin meloxicam metformin methocarbamol metoprolol metronidazole mirtazapine montelukast mucinex naproxen norco omeprazole ondansetron oxycodone pantoprazole penicillin percocet phentermine prednisone promethazine propranolol prozac ranitidine seroquel sertraline soma spironolactone suboxone tamiflu tamsulosin tizanidine toradol tramadol trazodone tylenol valium venlafaxine viagra vyvanse wellbutrin xanax xarelto zofran zoloft zyrtec more a-k · more l-z · by class · uk medicines for consumers medfacts drug information cerner multum drug information micromedex® advanced consumer medfacts natural products for professionals fda professional information a-z drug facts (facts & comparisons) ashp monographs (ahfs di) micromedex® carenotes medfacts natural products for researchers u.s. pharmaceutical sales statistics pharmaceutical company directory announcements physician's desk reference (pdr) latest fda new drug approvals azedra azedra (iobenguane i 131) is a radiotherapeutic product for malignant and/or recurrent pheochromocytoma and paraganglioma. perseris perseris (risperidone) is a once-monthly, subcutaneous formulation of the approved atypical antipsychotic risperidone indicated for the... orilissa orilissa (elagolix) is an orally administered gonadotropin-releasing hormone (gnrh) antagonist for the management of moderate to severe... more new drug approvals drugs in development (not yet approved) selinexor selinexor (kpt-330) is a first in class selective inhibitor of nuclear export (sine) xpo1 antagonist in development for the treatment of... cam2038 cam2038 (buprenorphine) is a long-acting partial opioid agonist formulation in development for the treatment of opioid use disorder. evenity evenity (romosozumab) is an anti-sclerostin monoclonal antibody in development for the treatment of osteoporosis in postmenopausal women at... more new drug applications drugs.com is the most popular, comprehensive and up-to-date source of drug information online. providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. posted today in news for health professionals four strategies help doctors make personal, professional gains in an article published in physicians practice, four strategies are presented to help physicians make personal and professional gains. the article provides four strategies for recommendations that can be relied upon for taking action, progressing toward goals, and feeling better about career and life goals. the first strategy is to take time for reflection... posted today in medical health highlights: july 30, 2018 here are some of the latest health and medical news developments, compiled by the editors of healthday: gun murders on the rise in u.s. gun murders are on the rise in the u.s. and are the most common type of murder, a federal government study says. between 2010 and 2016, gun murders accounted for more than 70 percent of all homicides. knives and... featured topic centers treating advanced rheumatoid arthritis ankylosing spondylitis center moderate-to-severe psoriasis doctor assessment moderate to severe psa treating multiple sclerosis facts about chronic dry eye posted today in medical majority in u.s. support medical pot, think it could fight opioid crisis americans strongly support medical marijuana, and a majority also believe that pot should be legal for recreational purposes, a new healthday/harris poll has found. nearly nine out of every 10 adults -- 85 percent -- believe that marijuana should be legalized for medical use, the poll reports. and more than half, 57 percent, support the legalization... posted 3 days ago in new drug approvals fda approves perseris (risperidone) for extended-release injectable suspension for the treatment of schizophrenia in adults slough, england and richmond, va., july 27, 2018 /prnewswire/ -- indivior plc (lon: indv) today announced that the u.s. food and drug administration (fda) has approved perseris, the first once-monthly subcutaneous risperidone-containing, long-acting injectable (lai) for the treatment of schizophrenia in adults. clinically relevant levels were reached... posted today in new drug approvals fda approves azedra (iobenguane i 131) for rare adrenal tumors the u.s. food and drug administration today approved azedra (iobenguane i 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic... posted 3 days ago in news for health professionals experimental drug slows mental decline in alzheimer's patients an experimental drug appears to slow mental decline by as m
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: drugs.com Registry Domain ID: 2799045_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2015-11-23T14:34:30-0800 Creation Date: 1998-12-17T21:00:00-0800 Registrar Registration Expiration Date: 2022-12-17T21:00:00-0800 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Domain Status: serverUpdateProhibited (https://www.icann.org/epp#serverUpdateProhibited) Domain Status: serverTransferProhibited (https://www.icann.org/epp#serverTransferProhibited) Domain Status: serverDeleteProhibited (https://www.icann.org/epp#serverDeleteProhibited) Registry Registrant ID: Registrant Name: Domain Administrator Registrant Organization: DNStination Inc. Registrant Street: 3450 Sacramento Street, Suite 405 Registrant City: San Francisco Registrant State/Province: CA Registrant Postal Code: 94118 Registrant Country: US Registrant Phone: +1.4155319335 Registrant Phone Ext: Registrant Fax: +1.4155319336 Registrant Fax Ext: Registrant Email: admin@dnstinations.com Registry Admin ID: Admin Name: Domain Administrator Admin Organization: DNStination Inc. Admin Street: 3450 Sacramento Street, Suite 405 Admin City: San Francisco Admin State/Province: CA Admin Postal Code: 94118 Admin Country: US Admin Phone: +1.4155319335 Admin Phone Ext: Admin Fax: +1.4155319336 Admin Fax Ext: Admin Email: admin@dnstinations.com Registry Tech ID: Tech Name: Domain Administrator Tech Organization: DNStination Inc. Tech Street: 3450 Sacramento Street, Suite 405 Tech City: San Francisco Tech State/Province: CA Tech Postal Code: 94118 Tech Country: US Tech Phone: +1.4155319335 Tech Phone Ext: Tech Fax: +1.4155319336 Tech Fax Ext: Tech Email: admin@dnstinations.com Name Server: a7-64.akam.net Name Server: a20-66.akam.net Name Server: a1-23.akam.net Name Server: a18-65.akam.net Name Server: a4-67.akam.net Name Server: a11-64.akam.net DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ >>> Last update of WHOIS database: 2017-07-09T07:11:20-0700 <<<
The Data in MarkMonitor.com's WHOIS database is provided by MarkMonitor.com for information purposes, and to assist persons in obtaining information about or related to a domain name registration record. MarkMonitor.com does not guarantee its accuracy. By submitting a WHOIS query, you agree that you will use this Data only for lawful purposes and that, under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail (spam); or (2) enable high volume, automated, electronic processes that apply to MarkMonitor.com (or its systems). MarkMonitor.com reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
MarkMonitor is the Global Leader in Online Brand Protection.
MarkMonitor Domain Management(TM) MarkMonitor Brand Protection(TM) MarkMonitor AntiPiracy(TM) MarkMonitor AntiFraud(TM) Professional and Managed Services
Visit MarkMonitor at http://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220
For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
drugs.com rapport :
Visitez le site